Seminal Vesicle-Sparing in Radical Cystectomy Shown to Improve Outcomes
Seminal vesicle-sparing radical cystectomy improved functional results over a median of 64 months without compromising oncologic outcomes, according to investigators.
All articles by Natasha Persaud
Oncologic Outcomes, Costs of High-Risk NMIBC Need to Improve
High-risk NMIBC progression more than doubled healthcare costs over 5 years compared with no progression, a study found.
Salvage Prostatectomy Complication Rates Differ by Primary PCa Therapy
Primary focal and radiation therapy for prostate cancer are associated with different rates of perioperative complications and long-term urinary continence recovery.
Cardiovascular Risk Factors Undertreated in Veterans With Prostate Cancer
In a study, 1 in 4 male veterans with prostate cancer failed to receive a comprehensive assessment of their cardiovascular risk factors.
Algorithm Proposed to Expand Cisplatin Eligibility for MIBC
A new algorithm developed by Canadian investigators aims to address underuse of cisplatin-based chemotherapy for muscle-invasive bladder cancer.
Localized PCa Therapies Safely Delivered During COVID-19 Peak at NYC Center
A cancer center in New York City safely managed patients with localized prostate cancer during the height of the COVID-19 pandemic in 2020, providing insights for handling a second COVID-19 wave.
Active Surveillance Appropriate for Favorable Intermediate-Risk PCa
Active surveillance may help many men with favorable intermediate-risk prostate cancer to avoid the adverse effects of treatment for 5 years.
Study Identifies Risk Factors for Urethral Recurrence After Radical Cystectomy
Study findings support surveillance for urethral recurrence after radical cystectomy.
Family History of Hereditary Cancer May Up PCa Progression Risk on Active Surveillance
Even men who test negative for mutations in the BRCA1/2 DNA repair genes may have increased risk for prostate cancer progression when they have certain family history.
Optimal Sequencing of ADT and RT for Low PSA Prostate Cancer Probed
During the COVID-19 pandemic, neoadjuvant ADT has been used as a way to delay initiation of daily radiation therapy, but it may not be appropriate for all men.
-
Loading...
-
Loading...
Next post in ASCO GU 2021
